Company intelligence / Profile preview

Neurognostics

Milwaukee, Wisconsin, United Statestandfonline.com ↗

Ownership: Private
Development stage: Commercial

Overview

Neurognostics developed and commercialized fMRI technologies aimed at improving early diagnosis of central nervous system disorders. Their solutions were used in both research and clinical settings to assess brain function using advanced imaging.

Therapeutic areas: OtherNeurology
Modalities: DeviceNon-pharmacological therapy (functional MRI technology)
Industry: Medical Imaging

Beyond the preview

Go deeper on Neurognostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurognostics.

Explore the full profile